Missionomics Back to app

Industrials

3M Company (MMM)

Industrials $83.4B market cap

Data as of July 13, 2026

Environment
58.00
People
72.00
Leadership
68.00

Environment story

3M's environmental score reflects severe PFAS contamination liabilities, incomplete net-zero credibility, and significant greenwashing risks. The company exited PFAS manufacturing by end of 2025 but faces $10.5–$12.5 billion in Public Water Supply (PWS) settlement obligations through 2036, plus ongoing site remediation and asset disposition costs. Scope 1&2 emissions and net-zero target year are not disclosed in source documents. Scope 3 emissions trajectory is undisclosed. Heavy reliance on litigation settlements and asset remediation rather than operational decarbonization suggests limited direct mitigation investments. The company's voluntary PFAS exit, while positive, does not offset the magnitude of environmental liabilities and lack of transparent climate commitments.

Criticisms on file

  • Public Water Supply (PWS) Settlement for PFAS Contamination
    Source: 3M 10-K 2025, Note 17 and MD&A; June 2023 class-action settlement approved March 2024. Total obligation $10.5–$12.5 billion payable 2024–2036. Covers drinking water claims by public water suppliers regarding PFAS.
  • PFAS Regulatory Designation and CERCLA Liability
    Source: 3M 10-K 2025, Risk Factors and MD&A. PFOA and PFOS designated as hazardous substances by EPA in 2024 under Comprehensive Environmental Response, Compensation and Liability Act (CERCLA), triggering joint and several liability for investigation and remediation at current/former facilities and off-site disposal locations.
  • Ongoing PFAS Litigation
    Source: 3M 10-K 2025, Risk Factors and Note 17. Company defending lawsuits concerning PFAS products and chemistries. Increased public and private litigation filed by states, counties, cities, utilities alleging harm to public and damages to natural resources, including in Aqueous Film Forming Foam (AFFF) multi-district litigation.
  • Asset Impairment and Facility Disposition Costs
    Source: 3M 10-K 2025, Risk Factors. Recorded $0.8 billion pre-tax charge in Q4 2022 for asset impairments related to PFAS exit. Ongoing costs for dismantling, cleaning, repurposing, and disposition of manufacturing facilities remain uncertain.
  • Third-Party PFAS-Containing Supply Chain Dependencies
    Source: 3M 10-K 2025, Risk Factors. Examples include lithium-ion batteries, printed circuit boards, seals, gaskets, and other products widely used in commerce. Company continues to evaluate feasibility and availability of PFAS-free substitutes; some remain unavailable or uneconomical, delaying transition.

Disclosed initiatives

  • PFAS Manufacturing Exit
    3M announced in December 2022 it would exit all PFAS manufacturing by end of 2025 and discontinue use of PFAS across its product portfolio by end of 2025. Completed PFAS manufacturing exit at end of 2025. Continues water treatment and site remediation activities for historical PFAS contamination.
    Eliminates future direct PFAS manufacturing emissions but does not address historical environmental contamination liability of $10.5–$12.5 billion.
  • Water Treatment and Site Remediation
    Company's water treatment assets at PFAS manufacturing facilities continue to treat residual PFAS in waste streams and remediate contaminated sites.
    Ongoing mitigation of historical contamination; costs and timeline uncertain.
  • PFAS Product Discontinuation
    Working to discontinue use of PFAS across product portfolio. Some third-party PFAS-containing materials (lithium-ion batteries, printed circuit boards, seals, gaskets) remain in supply chain where substitutes unavailable or infeasible.
    Partial progress; supply-chain PFAS dependencies persist in certain applications.

Social story

3M's social score reflects moderate governance on pay equity and diversity reporting, offset by significant litigation liabilities tied to product safety (Combat Arms Earplugs, asbestos-containing respirators) and documented supply-chain risks. CEO-to-median-worker pay ratio is not disclosed in source documents; workforce diversity metrics are not provided. No evidence of active union suppression or major recent strikes documented. The company has structured settlement frameworks for litigated product-safety claims ($6 billion CAE Settlement, $10.5–$12.5 billion PFAS settlements), but these do not constitute proactive social responsibility measures. Supply-chain labor practices and human-rights audits are not detailed in provided sources.

Criticisms on file

  • Combat Arms Earplugs Litigation and Settlement
    Source: 3M 10-K 2025, Note 17 and Risk Factors. Aearo Technologies sold Dual-Ended Combat Arms earplugs 1999–2015 (3M owned post-2008). Company faced significant litigation; August 2023 settlement for $6.0 billion (2023–2029) to resolve all claims. Reflects product defect claims and user injuries.
  • Asbestos-Containing Respirator Mask Litigation
    Source: 3M 10-K 2025, MD&A and Note 17. Ongoing litigation related to asbestos-containing respirator masks and other products. Net costs for significant litigation impacting operating income across business segments, with special item adjustments in 2023–2025.
  • Occupational Health and Safety Product Liability
    Source: 3M 10-K 2025, Risk Factors. Company's respirator and protective products subject to product liability claims, litigation, and regulatory inquiries. Indicates potential occupational health impacts on workers/users.

Disclosed initiatives

  • Combat Arms Earplugs (CAE) Settlement
    August 2023 settlement arrangement (as amended) with Aearo Entities to resolve litigation related to Dual-Ended Combat Arms earplugs sold 1999–2015. 3M contributes $6.0 billion 2023–2029. Over 99% of claimants participating.
    Resolves product-safety litigation but reflects past failure to ensure adequate product safety and testing.
  • Respirator Mask/Asbestos Litigation Reserves
    Company accruing for and defending lawsuits related to asbestos-containing respirator masks and related products (including non-Aearo items). Special item costs for significant litigation included in Safety and Industrial segment.
    Indicates unresolved product-safety liabilities and potential occupational health impacts.
  • Code of Conduct and Compliance Program
    Company maintains Code of Conduct for employees and Code of Business Conduct and Ethics for Directors. Chief Compliance Officer reports to Audit Committee on effectiveness of compliance program.
    Governance framework exists but effectiveness on labor practices and supply-chain ethics not demonstrated in source documents.
  • Supplier Responsibility Code
    Company has adopted Supplier Responsibility Code establishing requirements for suppliers and vendors. Legal compliance includes third-party risk assessment for suppliers and channel partners.
    Framework exists but specific audit findings, labor standards enforcement, and human-rights outcomes not disclosed.

Governance story

3M's governance score reflects a well-structured board with 90% independence, robust committee oversight, and best-practice disclosure policies. However, significant antitrust, litigation, and regulatory risks persist, partially offset by strong board refreshment and clear separation of Chair/CEO from Lead Independent Director. Board independence is strong; no dual-class share structure exists. Lobbying expenditures are not quantified in source documents. Active litigation reserves (PFAS, CAE, asbestos) total over $16 billion, indicating material regulatory and legal exposure. The company's governance practices are transparent and investor-friendly, but the magnitude of regulatory liabilities constrains the overall governance score.

Criticisms on file

  • PFAS Litigation and Regulatory Liability
    Source: 3M 10-K 2025, Note 17, Risk Factors, and MD&A. PWS Settlement $10.5–$12.5 billion (2024–2036); PFAS-related New Jersey Settlement (2025) with net costs for significant litigation and site remediation obligations updates. Ongoing governmental inquiries, lawsuits, EPA regulations, and international regulatory actions create material future cost uncertainty.
  • Combat Arms Earplugs Settlement
    Source: 3M 10-K 2025, Note 17 and Risk Factors. CAE Settlement $6.0 billion (2023–2029). Subject to risks including appellate challenges, additional litigation, and settlement implementation uncertainties.
  • Asbestos-Related Product Liability
    Source: 3M 10-K 2025, MD&A and Note 17. Ongoing litigation related to asbestos-containing respirator masks. Material special-item charges in 2023–2025 for net costs of significant litigation. Reserve adequacy subject to litigation outcome uncertainty.
  • Antitrust and Regulatory Exposure
    Source: 3M 10-K 2025, Risk Factors. Company subject to antitrust, competition, FCPA, anti-corruption, export control, trade sanctions, and other complex regulatory compliance risks. Failure to comply could result in significant civil/criminal liabilities, debarment from government contracts, and reputational harm.
  • Credit Rating Downgrade Risk
    Source: 3M 10-K 2025, Risk Factors. Credit ratings (Moody's A3, S&P BBB+, Fitch A-) support access to capital. Further downgrades would increase borrowing costs and impair liquidity. Leverage from litigation settlements and PFAS remediation obligations poses refinancing risk.
  • Solventum Separation Indemnification and Performance Risks
    Source: 3M 10-K 2025, Risk Factors. Following April 2024 spin-off of Solventum health-care business, 3M retained certain PFAS liabilities for Solventum-sold products for limited period. Separation agreements include transition services, supply arrangements, and intellectual property licenses subject to non-performance and indemnification risks.
  • Cybersecurity and Data Privacy Risks
    Source: 3M 10-K 2025, Risk Factors. Network disruptions, data breaches, and cyberattacks could result in loss of proprietary information, operational disruption, regulatory liability, and reputational harm. Enterprise resource planning (ERP) system implementation introduces additional vulnerability. While no material cyberattacks reported to date, incident risks remain significant.

Disclosed initiatives

  • Board Refreshment and Independence
    9 of 10 director nominees joined Board since 2021; 8 of 9 independent nominees are recent additions. New Lead Independent Director in 2024 (James R. Fitterling, Chair of Dow Inc.). All committee chairs new in role since 2023. Average board tenure 3.7 years; average age 60.7 years. 90% board independence; 100% independent committees.
    Strong board refreshment supports robust oversight and reduced entrenchment risk. New leadership enhances governance credibility.
  • Lead Independent Director with Robust Authority
    Lead Independent Director (James R. Fitterling) holds broad authority including presiding over executive sessions of independent directors, facilitating Board communications, and advising Chairman/CEO on governance matters. Full access to management and employees.
    Separation of Chair/CEO from Board leadership mitigates governance concentration risk.
  • Comprehensive Risk Oversight Structure
    Board delegates primary risk oversight to Audit Committee; assigns specific risks to designated committees (Compensation and Talent, Science/Technology/Sustainability, Nominating and Governance). Annual enterprise risk review includes PFAS litigation, cybersecurity, artificial intelligence, supply chain, and geopolitical risks. General Auditor conducts ongoing risk assessments and reports to Audit Committee and Board.
    Systematic risk governance framework supports early identification and mitigation of material exposures.
  • Political Activities and Lobbying Governance
    Voluntary disclosure of political activities, PAC contributions, and lobbying expenditures on company website since 2007. Disclosed trade associations with $25,000+ lobbying allocations. Board Nominating and Governance Committee oversees public policy and political activities.
    Transparency exceeds legal requirements; enables shareholder scrutiny of political engagement alignment with corporate strategy and ESG principles.
  • Cybersecurity and Artificial Intelligence Oversight
    Audit Committee oversees cybersecurity threats, internal controls, and data privacy. CIDO/CISO provides periodic reports; annual Board updates on cybersecurity. Board reviews risks and opportunities associated with AI use, integration into strategic initiatives, and operational implications.
    Proactive governance of emerging technology risks reflects evolving corporate governance standards.
  • Annual Say-on-Pay and Clawback Policy
    Annual advisory 'say-on-pay' shareholder vote. Comprehensive clawback policy covering executive compensation recovery for financial restatements, misconduct, and other triggering events.
    Shareholder accountability and executive compensation discipline support alignment of pay with performance and ethics.
  • No Poison Pill; Shareholder Rights
    No shareholder rights plan (poison pill). Annual director elections; majority voting for director elections; market-standard proxy access rights; shareholder right to call special meetings; no supermajority voting requirements.
    Governance structure provides strong shareholder rights and limits anti-takeover mechanisms.
  • Related Person Transaction Policy
    Board adopted written Related Person Transaction Policy administered by Nominating and Governance Committee. Threshold: transactions >$120,000 with Related Person interest referred for approval. Terms must be no less favorable than unaffiliated third-party transactions. No related-person transactions referred in 2025.
    Formal conflict-of-interest governance reduces self-dealing risk.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of 3M Company. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open 3M Company in the app for interactive charts and portfolio building.

Open 3M Company in Missionomics

More in Industrials

Space Exploration Technologies Corp. (SPCX) Caterpillar Inc. (CAT) GE Aerospace (GE) RTX Corporation (RTX) Union Pacific Corporation (UNP) The Boeing Company (BA)

Browse Companies · Methodology · Terms of Service · Privacy Policy · Back to Missionomics